Compound ID | 355
Synonym(s): cefclidin | E1040
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | This compound has isn’t stable at low concentrations against attack; additionally, it has low affinity for Citrobacter freundii |
Institute where first reported: | Eisai Co Ltd |
Year first mentioned: | 1987 |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
Reason Dropped: | 1995 Japan withdrew their pre-registration for Bacterial infections - "Unfortunately, the development of cefclidin was discontinued because eruption could not be avoided when co-administered with fluorescein, a corneal trauma indicator" (1) |
Chemical structure(s): | |
Canonical SMILES: | CO/N=C(/C1=NSC(=N1)N)\C(=O)N[C@@H]2C(=O)N3C(=C(C[N+]45CCC(CC4)(CC5)C(=O)N)CS[C@H]23)C(=O)[O-] |
Isomeric SMILES: | CO/N=C(/C1=NSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]45CCC(CC4)(CC5)C(=O)N)C(=O)[O-] |
InChI: | InChI=1S/C21H26N8O6S2/c1-35-26-11(14-25-20(23)37-27-14)15(30)24-12-16(31)28-13(18(32)33)10(9-36-17(12)28)8-29-5-2-21(3-6-29,4-7-29)19(22)34/h12,17H,2-9H2,1H3,(H5-,22,23,24,25,27,30,32,33,34)/b26-11-/t12-,17-,21?,29?/m1/s1 |
InChI Key: | JUVHVMCKLDZLGN-TVNFHGJBSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/6537446 |